Antonio Testa
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
-
- Head and Neck Cancer Studies 6
- Oncology 6
- Pancreatic and Hepatic Oncology Research 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Vittorio Gebbia (20 shared papers)Evaristo Maiello (4 shared papers)Massimo Lopez (3 shared papers)Francesco Giuliani (3 shared papers)Silvio Cigolari (2 shared papers)Generoso Uomo (2 shared papers)Giuseppe Colucci (2 shared papers)Maria Biglietto (2 shared papers)
In The Last Decade
Antonio Testa
19 papers receiving 943 citations
Peers
Comparison fields: 5 of 51
- Oncology 660
- Otorhinolaryngology 50
- Surgery 129
- Cancer Research 37
- Obstetrics and Gynecology 20
Countries citing papers authored by Antonio Testa
This map shows the geographic impact of Antonio Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Testa more than expected).
Fields of papers citing papers by Antonio Testa
This network shows the impact of papers produced by Antonio Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Testa. The network helps show where Antonio Testa may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Testa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale. | 2002 | 342 |
| 2 | 2002 | 270 | |
| 3 | 2007 | 86 | |
| 4 | 1994 | 61 | |
| 5 | 1996 | 44 | |
| 6 | 1993 | 36 | |
| 7 | 2002 | 31 | |
| 8 | 1995 | 22 | |
| 9 | 1997 | 19 | |
| 10 | 1998 | 19 | |
| 11 | 2002 | 16 | |
| 12 | 1995 | 15 | |
| 13 | 5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.). | 1999 | 15 |
| 14 | 1992 | 5 | |
| 15 | 1999 | 5 | |
| 16 | 1994 | 3 | |
| 17 | 1996 | 3 | |
| 18 | 2010 | 3 | |
| 19 | 1996 | 2 | |
| 20 | 2009 | 0 |
About Antonio Testa
Antonio Testa is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Hepatology, having authored 20 papers that have together received 997 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (6 papers), Nausea and vomiting management (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Gastric Cancer Management and Outcomes (2 papers), Lung Cancer Treatments and Mutations (1 paper), Lung Cancer Diagnosis and Treatment (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Oncology (660 citations), Otorhinolaryngology (50 citations), Surgery (129 citations), Cancer Research (37 citations) and Obstetrics and Gynecology (20 citations). Antonio Testa has collaborated with scholars based in Italy and Czechia. Frequent co-authors include Vittorio Gebbia, Evaristo Maiello, Massimo Lopez, Francesco Giuliani, Silvio Cigolari, Generoso Uomo, Giuseppe Colucci, Maria Biglietto, Giuseppe Emilio Cannata and Roberto Valenza. Their work appears in journals such as Anti-Cancer Drugs, Cancer, Oncology, ORL and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.